– Patients successfully self-managed PSVT episodes with etripamil which reduced need for ED intervention – – As in other studies, etripamil was well tolerated by patients – – Data to be featured during late breaking session at Heart Rhythm 2022 – MONTREAL and CHARLOTTE, N.C., April 30, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), […]
Rhythm
Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
On Its Anniversary, the Inventor of Measure-through Motion and Low Perfusion™ Pulse Oximetry Introduces the First Health Watch to Offer Accurate, Continuous Measurements IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) marks its 33rd anniversary today by announcing the limited market release of the W1™ health watch for consumers. The first of its kind, the […]
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott’s Ablation Device Remain Symptom-Free for at Least 15 Months
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial fibrillation experiencing an improved quality of life The catheter is part of Abbott’s suite of electrophysiology solutions designed to improve procedures to address cardiac arrythmias ABBOTT PARK, Ill., April 29, 2022 /PRNewswire/ — Abbott (NYSE: ABT) today […]
Impulse Dynamics Launches Optimizer Smart Mini CCM Delivery System
Smaller, Smarter, Long-lasting Device Gives Patients a Reason To Believe There Is a Tomorrow MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce today both FDA and CE Mark […]
B-Secur’s EKG Cloud Tech Improves Accuracy in Heart Health Monitoring
FDA-cleared HeartKey® 2.0 launches to power next generation of medical and consumer devices and platforms SAN FRANCISCO–(BUSINESS WIRE)–Global heart health technology company, B-Secur today launched HeartKey® 2.0. The new cloud-based software significantly reduces EKG signal noise, elevating EKG interpretation to new heights of efficiency and accuracy for clinicians and facilitating […]
FDA Clears Caretaker Medical’s Wireless Monitor for NonInvasive & Continuous Cardiac Output, Stroke Volume, and Advanced Hemodynamics
VitalStream™, Featuring Patented Pulse Decomposition Analysis™ technology becomes the World’s First Wireless Wearable Monitor for Continuous Blood Pressure and Advanced Hemodynamics – All with a single, easy-to-apply Finger Sensor Caretaker Medical, a digital health leader in continuous “beat by beat” wireless patient monitoring technologies, today announced that it has received […]
Vektor Medical to Present Positive Results from vMap Clinical Validation Study Showing 97.3% Mapping Accuracy for Atrial and Ventricular Arrhythmias
SAN FRANCISCO–(BUSINESS WIRE)–Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™. The study achieved statistically significant results of 98.7% in accurately identifying the regional arrhythmia source location for premature ventricular complex (PVC) and ventricular tachycardia (VT), 96.9% in accurately […]
Acutus Medical Announces Agreements to Fund Strategic Growth Priorities
CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a commitment letter from Deerfield Management Company (“Deerfield”), to refinance its existing debt with a new […]
Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022
– Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress – MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) — Volta Medical, a pioneering medtech startup advancing novel artificial intelligence (AI) algorithms to treat cardiac arrhythmias, today announced it […]
World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump’s U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS). The first implant was done by Duc Thinh Pham, MD, and Jane Wilcox, MD, at […]


